期刊
NATURE REVIEWS DRUG DISCOVERY
卷 9, 期 2, 页码 141-153出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd3048
关键词
-
资金
- Interdisciplinary Center for Clinical Research 'Biomat' within the Medical Faculty of RWTH Aachen University [T5, K1]
- Deutsche Forschungsgemeinschaft [DFG-FOR809]
- Austrian Science Fund (FWF) [T5] Funding Source: Austrian Science Fund (FWF)
Atherosclerosis is a chronic inflammatory disease of the arterial wall that is characterized by a disturbed equilibrium of immune responses and lipid accumulation, leading to the development of plaques. The atherogenic influx of mononuclear cells is orchestrated by chemokines and their receptors. Studies using gene-deficient mice and antagonists based on peptides and small molecules have generated insight into targeting chemokine-receptor axes for treating atherosclerosis, which might complement lipid-lowering strategies and risk factor modulation. Combined inhibition of multiple chemokine axes could interfere with the contributions of chemokines to disease progression at specific cells, stages or sites. In addition, the recently characterized heterophilic interactions of chemokines might present a novel target for the treatment and prevention of inflammatory diseases such as atherosclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据